Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:28 pm Sale | 2024-09-30 | 13G | Acelyrin, Inc. SLRN | T. Rowe Price Investment Management, Inc. | 10,431,846 10.500% | -67,054 (-0.64%) | Filing History |
| 2024-11-12 12:13 pm Unchanged | 2024-09-30 | 13G | Acelyrin, Inc. SLRN | The Vanguard Group | 4,066,989 4.070% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Acelyrin, Inc. SLRN | BlackRock Inc. BLK | 5,982,374 6.000% | 0 (Unchanged) | Filing History |
| 2024-11-04 10:56 am Sale | 2024-09-30 | 13G | Acelyrin, Inc. SLRN | The Vanguard Group | 4,066,989 4.070% | -2,088,921 (-33.93%) | Filing History |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Acelyrin, Inc. SLRN | BlackRock Inc. BLK | 5,982,374 6.000% | 5,982,374 (New Position) | Filing History |
| 2024-09-10 1:49 pm Purchase | 2024-08-31 | 13G | Acelyrin, Inc. SLRN | T. Rowe Price Investment Management, Inc. | 10,498,900 10.500% | 10,498,900 (New Position) | Filing History |
| 2024-08-12 09:40 am Sale | 2024-08-09 | 13G | Acelyrin, Inc. SLRN | FMR LLC | 3,884,690 3.922% | -4,937,581 (-55.97%) | Filing History |
| 2024-05-20 4:14 pm Purchase | 2024-05-08 | 13G | Acelyrin, Inc. SLRN | Integrated Core Strategies (US) LLC | 5,145,429 5.200% | 233,184 (+4.75%) | Filing History |
| 2024-04-19 4:12 pm Purchase | 2024-04-09 | 13G | Acelyrin, Inc. SLRN | Integrated Core Strategies (US) LLC | 4,912,245 4.990% | 4,912,245 (New Position) | Filing History |
| 2024-03-28 4:55 pm Purchase | 2023-12-31 | 13G | Acelyrin, Inc. SLRN | AyurMaya Capital Management Company LP | 9,334,735 9.600% | 9,334,735 (New Position) | Filing History |
| 2024-02-14 6:18 pm Purchase | 2023-12-31 | 13G | Acelyrin, Inc. SLRN | CITADEL ADVISORS LLC | 6,649,442 6.800% | 685,642 (+11.50%) | Filing History |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | Acelyrin, Inc. SLRN | The Vanguard Group | 6,155,910 6.320% | 6,155,910 (New Position) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Acelyrin, Inc. SLRN | FMR LLC | 8,822,271 9.063% | -432,601 (-4.67%) | Filing History |
| 2023-10-13 3:59 pm Purchase | 2023-10-09 | 13G | Acelyrin, Inc. SLRN | FMR LLC | 9,254,872 11.108% | 9,254,872 (New Position) | Filing History |
| 2023-10-10 09:09 am Purchase | 2023-10-09 | 13G | Acelyrin, Inc. SLRN | FIL Ltd | 9,254,872 11.108% | 9,254,872 (New Position) | Filing History |
| 2023-05-19 4:06 pm Purchase | 2023-05-09 | 13G | Acelyrin, Inc. SLRN | CITADEL ADVISORS LLC | 5,963,800 6.100% | 5,963,800 (New Position) | Filing History |
| 2023-05-19 4:00 pm Purchase | 2023-05-09 | 13D | Acelyrin, Inc. SLRN | AI ACEL LLC | 5,095,777 5.240% | 5,095,777 (New Position) | Filing History |
| 2023-05-19 2:54 pm Purchase | 2023-05-09 | 13D | Acelyrin, Inc. SLRN | Westlake BioPartners Fund II L.P. | 9,852,020 10.100% | 9,852,020 (New Position) | Filing History |